AAAAAA
Results:
1-24
|
Results: 24
Authors:
ROLSTON KVI
MANZULLO E
ELTING L
FRISBEEHUME S
RODRIGUEZ S
RUBENSTEIN EB
Citation: Kvi. Rolston et al., AMBULATORY MANAGEMENT OF VARICELLA-ZOSTER VIRUS-INFECTION IN IMMUNOCOMPROMISED CANCER-PATIENTS, Supportive care in cancer, 6(1), 1998, pp. 57-62
Authors:
CANTOR SB
HUDSON DV
LICHTIGER B
RUBENSTEIN EB
Citation: Sb. Cantor et al., COSTS OF BLOOD-TRANSFUSION - A PROCESS-FLOW ANALYSIS, Journal of clinical oncology, 16(7), 1998, pp. 2364-2370
Authors:
ELTING LS
RUBENSTEIN EB
ROLSTON KVI
BODEY GP
Citation: Ls. Elting et al., OUTCOMES OF BACTEREMIA IN PATIENTS WITH CANCER AND NEUTROPENIA - OBSERVATIONS FROM 2 DECADES OF EPIDEMIOLOGIC AND CLINICAL-TRIALS, Clinical infectious diseases, 25(2), 1997, pp. 247-259
Authors:
SUNDARARAJAN V
RUBENSTEIN EB
ROLSTON KVI
ELTING LS
Citation: V. Sundararajan et al., CONTROVERSIES IN NEW ANTIBIOTIC-THERAPY FOR AMBULATORY PATIENTS, Supportive care in cancer, 5(5), 1997, pp. 358-364
Authors:
ESCALANTE CP
MARTIN CG
ELTING KS
RUBENSTEIN EB
Citation: Cp. Escalante et al., MEDICAL FUTILITY AND APPROPRIATE MEDICAL-CARE IN PATIENTS WHOSE DEATHIS THOUGHT TO BE IMMINENT, Supportive care in cancer, 5(4), 1997, pp. 274-280
Authors:
ESCALANTE CP
RUBENSTEIN EB
ROLSTON KVI
Citation: Cp. Escalante et al., OUTPATIENT ANTIBIOTIC-THERAPY FOR FEBRILE EPISODES IN LOW-RISK NEUTROPENIC PATIENTS WITH CANCER, Cancer investigation, 15(3), 1997, pp. 237-242
Authors:
RUBENSTEIN EB
GRALLA RJ
HAINSWORTH JD
HESKETH PJ
GROTE TH
MODIANO MR
KHOJASTEH A
KALMAN LA
BENEDICT CR
HAHNE WF
Citation: Eb. Rubenstein et al., RANDOMIZED, DOUBLE-BLIND, DOSE-RESPONSE TRIAL ACROSS 4 ORAL DOSES OF DOLASETRON FOR THE PREVENTION OF ACUTE EMESIS AFTER MODERATELY EMETOGENIC CHEMOTHERAPY, Cancer, 79(6), 1997, pp. 1216-1224
Authors:
ESCALANTE CP
RUBENSTEIN EB
ROLSTON KVI
Citation: Cp. Escalante et al., OUTPATIENT ANTIBIOTIC-TREATMENT IN LOW-RISK FEBRILE NEUTROPENIC CANCER-PATIENTS, Supportive care in cancer, 4(5), 1996, pp. 358-363
Authors:
ROLSTON KVI
RUBENSTEIN EB
FREIFELD A
Citation: Kvi. Rolston et al., EARLY EMPIRIC ANTIBIOTIC-THERAPY FOR FEBRILE NEUTROPENIA PATIENTS AT LOW-RISK, Infectious disease clinics of North America, 10(2), 1996, pp. 223
Authors:
RUBENSTEIN EB
ENGEL NL
Citation: Eb. Rubenstein et Nl. Engel, SUCCESSFUL TREATMENT OF TRANSVESTIC FETISHISM WITH SERTRALINE AND LITHIUM, The Journal of clinical psychiatry, 57(2), 1996, pp. 92-92
Authors:
ESCALANTE CP
MARTIN CG
ELTING LS
CANTOR SB
HARLE TS
PRICE KJ
KISH SK
MANZULLO EF
RUBENSTEIN EB
Citation: Cp. Escalante et al., DYSPNEA IN CANCER-PATIENTS - ETIOLOGY, RESOURCE UTILIZATION, AND SURVIVAL-IMPLICATIONS IN A MANAGED CARE WORLD, Cancer, 78(6), 1996, pp. 1314-1319
Authors:
RUBENSTEIN EB
ROLSTON KVI
Citation: Eb. Rubenstein et Kvi. Rolston, OUTPATIENT TREATMENT OF FEBRILE NEUTROPENIC PATIENTS WITH CANCER, European journal of cancer, 31A(1), 1995, pp. 2-4
Authors:
ROLSTON KVI
DHOLAKIA N
RODRIGUEZ S
RUBENSTEIN EB
Citation: Kvi. Rolston et al., NATURE AND OUTCOME OF FEBRILE EPISODES IN PATIENTS WITH PANCREATIC AND HEPATOBILIARY CANCER, Supportive care in cancer, 3(6), 1995, pp. 414-417
Authors:
RUBENSTEIN EB
FENDER A
ROLSTON KVI
ELTING LS
PRASCO P
PALMER J
RAAD I
POLLOCK RE
FRISBEEHUME S
LAURENCE D
HOHN DC
Citation: Eb. Rubenstein et al., VASCULAR ACCESS BY PHYSICIAN ASSISTANTS - EVALUATION OF AN IMPLANTABLE PERIPHERAL PORT SYSTEM IN CANCER-PATIENTS, Journal of clinical oncology, 13(6), 1995, pp. 1513-1519
Authors:
ROLSTON KVI
RUBENSTEIN EB
Citation: Kvi. Rolston et Eb. Rubenstein, ACUTE-RENAL-FAILURE ATTRIBUTABLE TO CIPROFLOXACIN IN A PATIENT WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME - REPLY, Archives of internal medicine, 155(1), 1995, pp. 114-115
Authors:
RUBENSTEIN EB
ROLSTON K
Citation: Eb. Rubenstein et K. Rolston, OUTPATIENT MANAGEMENT OF FEBRILE EPISODES IN NEUTROPENIC CANCER-PATIENTS, Supportive care in cancer, 2(6), 1994, pp. 369-373
Authors:
RUBENSTEIN EB
Citation: Eb. Rubenstein, COSTS AND BENEFITS OF OUTPATIENT THERAPY, Supportive care in cancer, 2(5), 1994, pp. 307-311
Authors:
RUBENSTEIN EB
ROLSTON K
ELTING L
Citation: Eb. Rubenstein et al., OUTPATIENT ANTIBIOTIC-THERAPY IN FEBRILE NEUTROPENIC PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT, Journal of clinical oncology, 12(11), 1994, pp. 2516-2517
Authors:
RUBENSTEIN EB
ELTING LS
Citation: Eb. Rubenstein et Ls. Elting, REEXAMINATION OF CLINICAL ASPECTS OF PHARMACOECONOMIC ANALYSIS, American journal of hospital pharmacy, 51(23), 1994, pp. 2970-2971
Authors:
RUBENSTEIN EB
ELTING LS
Citation: Eb. Rubenstein et Ls. Elting, PHARMACOECONOMIC ANALYSES - WHOSE PERSPECTIVE COUNTS AND COSTS THE MOST, American journal of hospital pharmacy, 51(12), 1994, pp. 1564-1569
Authors:
ROLSTON KVI
RUBENSTEIN EB
Citation: Kvi. Rolston et Eb. Rubenstein, FEVER IN PATIENTS WITH NEUTROPENIA, The New England journal of medicine, 329(17), 1993, pp. 1279-1280
Authors:
RUBENSTEIN EB
ROLSTON K
BENJAMIN RS
LOEWY J
ESCALANTE C
MANZULLO E
HUGHES P
MORELAND B
FENDER A
KENNEDY K
HOLMES F
ELTING L
BODEY GP
Citation: Eb. Rubenstein et al., OUTPATIENT TREATMENT OF FEBRILE EPISODES IN LOW-RISK NEUTROPENIC PATIENTS WITH CANCER, Cancer, 71(11), 1993, pp. 3640-3646
Authors:
ROLSTON KVI
RUBENSTEIN EB
Citation: Kvi. Rolston et Eb. Rubenstein, CIPROFLOXACIN NEPHROTOXICITY - REPLY, Archives of internal medicine, 153(23), 1993, pp. 2706-2706
Authors:
LO WK
ROLSTON KVI
RUBENSTEIN EB
BODEY GP
Citation: Wk. Lo et al., CIPROFLOXACIN-INDUCED NEPHROTOXICITY IN PATIENTS WITH CANCER, Archives of internal medicine, 153(10), 1993, pp. 1258-1262
Risultati:
1-24
|